Mumps - Clinical trials 

Clinical trials for Mumps

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Mumps. For all clinical trials, go to clinical trials search

This list shows clinical trials for Mumps

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Mumps
Title Recruitment status Location
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants Not recruiting United Kingdom
The DECIDA study: Detailed Evaluation of a Childhood Immunisation Decision Aid Not recruiting United Kingdom
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of GlaxoSmithKline Biologicals’ dTpa-IPV vaccine (Boostrix Polio) compared with Sanofi Pasteur MSD’s dTpa-IPV vaccine (Repevax), when co-administered with GSK Biologicals’ MMR vaccine (Priorix) in 3 and 4-year-old healthy children. - DTPA-IPV (BOOSTRIX-IPV)-009 Authorised United Kingdom
A Study of the Interaction between BCG And Meningitis C immunisation: BAM Authorised United Kingdom
The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants Recruiting Israel
Clinical Study to assess the immune response and safety of Measles, Mumps and Rubella (MMR) vaccine (Live) (Freeze-dried) of M/s Cadila Healthcare Ltd. in healthy pediatric subjects aged 15-18 months Recruiting India
A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children Recruiting China
Topical coating of measles-mumps-rubella vaccine for the treatment of respiratory papilloma Recruiting China
Ontogeny of Measles Immunity in Infants Recruiting United States
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age Recruiting Korea, Republic of